Q1 EPS Estimate for Soleno Therapeutics Lifted by Analyst

Chronological Source Flow
Back

AI Fusion Summary

Analysts at HC Wainwright issued revised Q1 and Q2 2026 earnings forecasts for three biotech firms, lowering the estimate for Beam Therapeutics and raising the estimates for both Soleno Therapeutics and Eton Pharmaceuticals.
06/03 08:02 defenseworld.net
3 Πηγές
06/03 08:03 defenseworld.net
06/03 08:26 defenseworld.net
Comments
Loading...
0